JACC:室性早搏心肌病神经重塑的特点

2020-01-08 不详 MedSci原创

室性早搏心肌病(PVC-CM)神经重塑的存在及其意义尚不清楚。本研究旨在探讨犬PVC-CM模型的心交感神经平衡和心律失常发生的特点。在本研究中,对12只犬植入心外膜起搏器和无线遥测装置,记录左星状神经节(SNA)、左心迷走神经(VNA)和动脉血压的心律和神经活动(NA),应用二联PVCs(200ms耦合)12周诱导7只动物形成PVC-CM,然后停用4周,使左室射血分数(LVEF)完全恢复,并与5只

室性早搏心肌病(PVC-CM)神经重塑的存在及其意义尚不清楚。本研究旨在探讨犬PVC-CM模型的心交感神经平衡和心律失常发生的特点。

在本研究中,对12只犬植入心外膜起搏器和无线遥测装置,记录左星状神经节(SNA)、左心迷走神经(VNA)和动脉血压的心律和神经活动(NA),应用二联PVCs(200ms耦合)12周诱导7只动物形成PVC-CM,然后停用4周,使左室射血分数(LVEF)完全恢复,并与5只假对照组比较。经过12周的PVC,LVEF (p = 0.006)和dP/dT (p = 0.007)均有所下降,静息SNA(p=0.002)和VNA(p=0.04)、运动SNA(p=0.01)、诱发PVCs的SNA反应(p=0.005)、静息心率(HR)和运动(p<0.04)均有所增加,而心率变异性(HRV)降低(p=0.009)。PVC-CM的动物会出现自发性心房(p=0.02)和室性心律失常(p=0.03)。可乐定可以抑制SNA,消除所有心律失常。在停止PVC四周后,LVEF(p=0.01)、dP/dT(p=0.047)和静息VNA(p=0.03)恢复到基线水平。然而,SNA、静息心率、心率变异性、房性心律失常(p=0.03)和室性心律失常(p=0.03)持续存在。

研究结果显示,PVC-CM神经重塑的特点是心外交感神经过度支配与交感神经亢进,且与左室射血分数的恢复无关。心交感神经平衡的改变是房性和室性心律失常发生的重要触发和基础。

原始出处:

本文系梅斯医学(MedSci)原创编译整理,转载需授权


版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (7)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1854626, encodeId=cc7c18546265b, content=<a href='/topic/show?id=48351020537' target=_blank style='color:#2F92EE;'>#JACC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10205, encryptionId=48351020537, topicName=JACC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=55ce62, createdName=hbwxf, createdTime=Fri Jul 03 00:49:00 CST 2020, time=2020-07-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1801966, encodeId=72251801966e2, content=<a href='/topic/show?id=7e1be460054' target=_blank style='color:#2F92EE;'>#神经重塑#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=74600, encryptionId=7e1be460054, topicName=神经重塑)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aae2431, createdName=venlin, createdTime=Tue Apr 14 00:49:00 CST 2020, time=2020-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=377997, encodeId=18833e799737, content=很好的学习机会, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/04/12/cd30eefc465f70dc4dad89bd57479781.jpg, createdBy=02be2318568, createdName=一天没事干, createdTime=Fri Jan 10 08:56:30 CST 2020, time=2020-01-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1326453, encodeId=8cb7132645300, content=<a href='/topic/show?id=96c71804b7' target=_blank style='color:#2F92EE;'>#ACC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1804, encryptionId=96c71804b7, topicName=ACC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1e452500029, createdName=12498568m50暂无昵称, createdTime=Fri Jan 10 00:49:00 CST 2020, time=2020-01-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1424071, encodeId=e20d14240e1d7, content=<a href='/topic/show?id=607146230d1' target=_blank style='color:#2F92EE;'>#室性早搏#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=46230, encryptionId=607146230d1, topicName=室性早搏)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8db03894351, createdName=hunizi006, createdTime=Fri Jan 10 00:49:00 CST 2020, time=2020-01-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1521422, encodeId=c509152142240, content=<a href='/topic/show?id=eee459319c0' target=_blank style='color:#2F92EE;'>#早搏#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=59319, encryptionId=eee459319c0, topicName=早搏)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a1f611339865, createdName=bioon7, createdTime=Fri Jan 10 00:49:00 CST 2020, time=2020-01-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1622425, encodeId=a7dc1622425a7, content=<a href='/topic/show?id=b9578094833' target=_blank style='color:#2F92EE;'>#肌病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=80948, encryptionId=b9578094833, topicName=肌病)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=395f25, createdName=爆笑小医, createdTime=Fri Jan 10 00:49:00 CST 2020, time=2020-01-10, status=1, ipAttribution=)]
    2020-07-03 hbwxf
  2. [GetPortalCommentsPageByObjectIdResponse(id=1854626, encodeId=cc7c18546265b, content=<a href='/topic/show?id=48351020537' target=_blank style='color:#2F92EE;'>#JACC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10205, encryptionId=48351020537, topicName=JACC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=55ce62, createdName=hbwxf, createdTime=Fri Jul 03 00:49:00 CST 2020, time=2020-07-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1801966, encodeId=72251801966e2, content=<a href='/topic/show?id=7e1be460054' target=_blank style='color:#2F92EE;'>#神经重塑#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=74600, encryptionId=7e1be460054, topicName=神经重塑)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aae2431, createdName=venlin, createdTime=Tue Apr 14 00:49:00 CST 2020, time=2020-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=377997, encodeId=18833e799737, content=很好的学习机会, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/04/12/cd30eefc465f70dc4dad89bd57479781.jpg, createdBy=02be2318568, createdName=一天没事干, createdTime=Fri Jan 10 08:56:30 CST 2020, time=2020-01-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1326453, encodeId=8cb7132645300, content=<a href='/topic/show?id=96c71804b7' target=_blank style='color:#2F92EE;'>#ACC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1804, encryptionId=96c71804b7, topicName=ACC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1e452500029, createdName=12498568m50暂无昵称, createdTime=Fri Jan 10 00:49:00 CST 2020, time=2020-01-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1424071, encodeId=e20d14240e1d7, content=<a href='/topic/show?id=607146230d1' target=_blank style='color:#2F92EE;'>#室性早搏#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=46230, encryptionId=607146230d1, topicName=室性早搏)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8db03894351, createdName=hunizi006, createdTime=Fri Jan 10 00:49:00 CST 2020, time=2020-01-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1521422, encodeId=c509152142240, content=<a href='/topic/show?id=eee459319c0' target=_blank style='color:#2F92EE;'>#早搏#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=59319, encryptionId=eee459319c0, topicName=早搏)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a1f611339865, createdName=bioon7, createdTime=Fri Jan 10 00:49:00 CST 2020, time=2020-01-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1622425, encodeId=a7dc1622425a7, content=<a href='/topic/show?id=b9578094833' target=_blank style='color:#2F92EE;'>#肌病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=80948, encryptionId=b9578094833, topicName=肌病)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=395f25, createdName=爆笑小医, createdTime=Fri Jan 10 00:49:00 CST 2020, time=2020-01-10, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1854626, encodeId=cc7c18546265b, content=<a href='/topic/show?id=48351020537' target=_blank style='color:#2F92EE;'>#JACC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10205, encryptionId=48351020537, topicName=JACC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=55ce62, createdName=hbwxf, createdTime=Fri Jul 03 00:49:00 CST 2020, time=2020-07-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1801966, encodeId=72251801966e2, content=<a href='/topic/show?id=7e1be460054' target=_blank style='color:#2F92EE;'>#神经重塑#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=74600, encryptionId=7e1be460054, topicName=神经重塑)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aae2431, createdName=venlin, createdTime=Tue Apr 14 00:49:00 CST 2020, time=2020-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=377997, encodeId=18833e799737, content=很好的学习机会, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/04/12/cd30eefc465f70dc4dad89bd57479781.jpg, createdBy=02be2318568, createdName=一天没事干, createdTime=Fri Jan 10 08:56:30 CST 2020, time=2020-01-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1326453, encodeId=8cb7132645300, content=<a href='/topic/show?id=96c71804b7' target=_blank style='color:#2F92EE;'>#ACC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1804, encryptionId=96c71804b7, topicName=ACC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1e452500029, createdName=12498568m50暂无昵称, createdTime=Fri Jan 10 00:49:00 CST 2020, time=2020-01-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1424071, encodeId=e20d14240e1d7, content=<a href='/topic/show?id=607146230d1' target=_blank style='color:#2F92EE;'>#室性早搏#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=46230, encryptionId=607146230d1, topicName=室性早搏)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8db03894351, createdName=hunizi006, createdTime=Fri Jan 10 00:49:00 CST 2020, time=2020-01-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1521422, encodeId=c509152142240, content=<a href='/topic/show?id=eee459319c0' target=_blank style='color:#2F92EE;'>#早搏#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=59319, encryptionId=eee459319c0, topicName=早搏)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a1f611339865, createdName=bioon7, createdTime=Fri Jan 10 00:49:00 CST 2020, time=2020-01-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1622425, encodeId=a7dc1622425a7, content=<a href='/topic/show?id=b9578094833' target=_blank style='color:#2F92EE;'>#肌病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=80948, encryptionId=b9578094833, topicName=肌病)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=395f25, createdName=爆笑小医, createdTime=Fri Jan 10 00:49:00 CST 2020, time=2020-01-10, status=1, ipAttribution=)]
    2020-01-10 一天没事干

    很好的学习机会

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1854626, encodeId=cc7c18546265b, content=<a href='/topic/show?id=48351020537' target=_blank style='color:#2F92EE;'>#JACC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10205, encryptionId=48351020537, topicName=JACC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=55ce62, createdName=hbwxf, createdTime=Fri Jul 03 00:49:00 CST 2020, time=2020-07-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1801966, encodeId=72251801966e2, content=<a href='/topic/show?id=7e1be460054' target=_blank style='color:#2F92EE;'>#神经重塑#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=74600, encryptionId=7e1be460054, topicName=神经重塑)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aae2431, createdName=venlin, createdTime=Tue Apr 14 00:49:00 CST 2020, time=2020-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=377997, encodeId=18833e799737, content=很好的学习机会, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/04/12/cd30eefc465f70dc4dad89bd57479781.jpg, createdBy=02be2318568, createdName=一天没事干, createdTime=Fri Jan 10 08:56:30 CST 2020, time=2020-01-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1326453, encodeId=8cb7132645300, content=<a href='/topic/show?id=96c71804b7' target=_blank style='color:#2F92EE;'>#ACC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1804, encryptionId=96c71804b7, topicName=ACC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1e452500029, createdName=12498568m50暂无昵称, createdTime=Fri Jan 10 00:49:00 CST 2020, time=2020-01-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1424071, encodeId=e20d14240e1d7, content=<a href='/topic/show?id=607146230d1' target=_blank style='color:#2F92EE;'>#室性早搏#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=46230, encryptionId=607146230d1, topicName=室性早搏)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8db03894351, createdName=hunizi006, createdTime=Fri Jan 10 00:49:00 CST 2020, time=2020-01-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1521422, encodeId=c509152142240, content=<a href='/topic/show?id=eee459319c0' target=_blank style='color:#2F92EE;'>#早搏#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=59319, encryptionId=eee459319c0, topicName=早搏)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a1f611339865, createdName=bioon7, createdTime=Fri Jan 10 00:49:00 CST 2020, time=2020-01-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1622425, encodeId=a7dc1622425a7, content=<a href='/topic/show?id=b9578094833' target=_blank style='color:#2F92EE;'>#肌病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=80948, encryptionId=b9578094833, topicName=肌病)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=395f25, createdName=爆笑小医, createdTime=Fri Jan 10 00:49:00 CST 2020, time=2020-01-10, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=1854626, encodeId=cc7c18546265b, content=<a href='/topic/show?id=48351020537' target=_blank style='color:#2F92EE;'>#JACC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10205, encryptionId=48351020537, topicName=JACC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=55ce62, createdName=hbwxf, createdTime=Fri Jul 03 00:49:00 CST 2020, time=2020-07-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1801966, encodeId=72251801966e2, content=<a href='/topic/show?id=7e1be460054' target=_blank style='color:#2F92EE;'>#神经重塑#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=74600, encryptionId=7e1be460054, topicName=神经重塑)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aae2431, createdName=venlin, createdTime=Tue Apr 14 00:49:00 CST 2020, time=2020-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=377997, encodeId=18833e799737, content=很好的学习机会, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/04/12/cd30eefc465f70dc4dad89bd57479781.jpg, createdBy=02be2318568, createdName=一天没事干, createdTime=Fri Jan 10 08:56:30 CST 2020, time=2020-01-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1326453, encodeId=8cb7132645300, content=<a href='/topic/show?id=96c71804b7' target=_blank style='color:#2F92EE;'>#ACC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1804, encryptionId=96c71804b7, topicName=ACC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1e452500029, createdName=12498568m50暂无昵称, createdTime=Fri Jan 10 00:49:00 CST 2020, time=2020-01-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1424071, encodeId=e20d14240e1d7, content=<a href='/topic/show?id=607146230d1' target=_blank style='color:#2F92EE;'>#室性早搏#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=46230, encryptionId=607146230d1, topicName=室性早搏)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8db03894351, createdName=hunizi006, createdTime=Fri Jan 10 00:49:00 CST 2020, time=2020-01-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1521422, encodeId=c509152142240, content=<a href='/topic/show?id=eee459319c0' target=_blank style='color:#2F92EE;'>#早搏#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=59319, encryptionId=eee459319c0, topicName=早搏)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a1f611339865, createdName=bioon7, createdTime=Fri Jan 10 00:49:00 CST 2020, time=2020-01-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1622425, encodeId=a7dc1622425a7, content=<a href='/topic/show?id=b9578094833' target=_blank style='color:#2F92EE;'>#肌病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=80948, encryptionId=b9578094833, topicName=肌病)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=395f25, createdName=爆笑小医, createdTime=Fri Jan 10 00:49:00 CST 2020, time=2020-01-10, status=1, ipAttribution=)]
  6. [GetPortalCommentsPageByObjectIdResponse(id=1854626, encodeId=cc7c18546265b, content=<a href='/topic/show?id=48351020537' target=_blank style='color:#2F92EE;'>#JACC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10205, encryptionId=48351020537, topicName=JACC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=55ce62, createdName=hbwxf, createdTime=Fri Jul 03 00:49:00 CST 2020, time=2020-07-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1801966, encodeId=72251801966e2, content=<a href='/topic/show?id=7e1be460054' target=_blank style='color:#2F92EE;'>#神经重塑#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=74600, encryptionId=7e1be460054, topicName=神经重塑)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aae2431, createdName=venlin, createdTime=Tue Apr 14 00:49:00 CST 2020, time=2020-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=377997, encodeId=18833e799737, content=很好的学习机会, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/04/12/cd30eefc465f70dc4dad89bd57479781.jpg, createdBy=02be2318568, createdName=一天没事干, createdTime=Fri Jan 10 08:56:30 CST 2020, time=2020-01-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1326453, encodeId=8cb7132645300, content=<a href='/topic/show?id=96c71804b7' target=_blank style='color:#2F92EE;'>#ACC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1804, encryptionId=96c71804b7, topicName=ACC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1e452500029, createdName=12498568m50暂无昵称, createdTime=Fri Jan 10 00:49:00 CST 2020, time=2020-01-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1424071, encodeId=e20d14240e1d7, content=<a href='/topic/show?id=607146230d1' target=_blank style='color:#2F92EE;'>#室性早搏#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=46230, encryptionId=607146230d1, topicName=室性早搏)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8db03894351, createdName=hunizi006, createdTime=Fri Jan 10 00:49:00 CST 2020, time=2020-01-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1521422, encodeId=c509152142240, content=<a href='/topic/show?id=eee459319c0' target=_blank style='color:#2F92EE;'>#早搏#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=59319, encryptionId=eee459319c0, topicName=早搏)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a1f611339865, createdName=bioon7, createdTime=Fri Jan 10 00:49:00 CST 2020, time=2020-01-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1622425, encodeId=a7dc1622425a7, content=<a href='/topic/show?id=b9578094833' target=_blank style='color:#2F92EE;'>#肌病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=80948, encryptionId=b9578094833, topicName=肌病)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=395f25, createdName=爆笑小医, createdTime=Fri Jan 10 00:49:00 CST 2020, time=2020-01-10, status=1, ipAttribution=)]
    2020-01-10 bioon7
  7. [GetPortalCommentsPageByObjectIdResponse(id=1854626, encodeId=cc7c18546265b, content=<a href='/topic/show?id=48351020537' target=_blank style='color:#2F92EE;'>#JACC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10205, encryptionId=48351020537, topicName=JACC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=55ce62, createdName=hbwxf, createdTime=Fri Jul 03 00:49:00 CST 2020, time=2020-07-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1801966, encodeId=72251801966e2, content=<a href='/topic/show?id=7e1be460054' target=_blank style='color:#2F92EE;'>#神经重塑#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=74600, encryptionId=7e1be460054, topicName=神经重塑)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aae2431, createdName=venlin, createdTime=Tue Apr 14 00:49:00 CST 2020, time=2020-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=377997, encodeId=18833e799737, content=很好的学习机会, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/04/12/cd30eefc465f70dc4dad89bd57479781.jpg, createdBy=02be2318568, createdName=一天没事干, createdTime=Fri Jan 10 08:56:30 CST 2020, time=2020-01-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1326453, encodeId=8cb7132645300, content=<a href='/topic/show?id=96c71804b7' target=_blank style='color:#2F92EE;'>#ACC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1804, encryptionId=96c71804b7, topicName=ACC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1e452500029, createdName=12498568m50暂无昵称, createdTime=Fri Jan 10 00:49:00 CST 2020, time=2020-01-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1424071, encodeId=e20d14240e1d7, content=<a href='/topic/show?id=607146230d1' target=_blank style='color:#2F92EE;'>#室性早搏#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=46230, encryptionId=607146230d1, topicName=室性早搏)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8db03894351, createdName=hunizi006, createdTime=Fri Jan 10 00:49:00 CST 2020, time=2020-01-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1521422, encodeId=c509152142240, content=<a href='/topic/show?id=eee459319c0' target=_blank style='color:#2F92EE;'>#早搏#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=59319, encryptionId=eee459319c0, topicName=早搏)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a1f611339865, createdName=bioon7, createdTime=Fri Jan 10 00:49:00 CST 2020, time=2020-01-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1622425, encodeId=a7dc1622425a7, content=<a href='/topic/show?id=b9578094833' target=_blank style='color:#2F92EE;'>#肌病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=80948, encryptionId=b9578094833, topicName=肌病)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=395f25, createdName=爆笑小医, createdTime=Fri Jan 10 00:49:00 CST 2020, time=2020-01-10, status=1, ipAttribution=)]

相关资讯

Eur Heart J:慢性系统性炎症是癌症的危险因素

血浆高敏C反应蛋白(CRP)的升高代表的低水平炎症反应是心血管疾病(CVD)的危险因素之一,同样也可能增加癌症的发表风险。本研究的目的旨在评估稳定性CVD患者低水平系统系炎症与癌症发生的相关性。本研究纳入分析了7178名稳定性CVD且血浆CRP≤10mg/L的患者,经过平均8.3年时间的随访,有1072名患者诊断为癌症,CRP水平与总体癌症发生率相关(HR 1.35; 95% CI 1.10-1.

Eur Heart J:高甘油三酯会增加动脉粥样硬化性心血管病患者的风险

REDUCE-IT临床试验结果显示乙醇酸盐可以改善动脉粥样硬化性心血管病(ASCVD)伴高甘油三酯血症患者的预后,在患有ASCVD的人群中,本研究试图量化与高甘油三酯血症相关的ASCVD事件。在ASCVD的患者中,本研究探究了甘油三酯(TG)和ASCVD事件(首次出现心肌梗死、不稳定心绞痛、中风或短暂缺血发作、冠状动脉血运重建或心血管死亡)之间的相关性。TG 135-499mg/dL(1.52-5

葛均波:2019年心血管治疗进展回顾

转眼间又是一年就要过去了,现将2019年心血管介入治疗领域可能改变目前临床实践的重要研究和亮点研究回顾如下。

(一)、血管紧张素受体脑啡肽抑制剂(ARNI)在<

EHJ连发8文,总结2019年度心血管进展

2020年1月6日,欧洲心脏病杂志(European Heart Journal, EHJ)在线发表了《The year in cardiology 2019》系列文章,盘点了2019年心血管领域取得的重要进展。涉及到的领域包括:急性冠脉综合征、主动脉和外周循环、心律失常、心衰、心血管影像、冠脉介入、心血管疾病预防、心脏瓣膜病。平常没时间追踪进展?赶紧查看这些精彩总结,快速了解心血管领域最新进展吧

Eur Heart J:预测早期乳腺癌患者心血管风险的评分体系

本研究的目的旨在开发一个评分来预测早期乳腺癌(EBC)后主要心血管事件(MACE)的风险,以促进潜在的心脏毒性治疗和干预以减少心血管风险的个性化决策。本研究纳入了2003-2014年被诊断为EBC的患者,其中三分之二患者用于风险评分的推导;其余的用于验证,主要终点事件是急性心梗、不稳定性心绞痛、短暂性缺血发作、中风、周围血管疾病、心力衰竭或心血管死亡的复合事件。最终,有60294名EBC患者用于风

Eur Heart J:缺血性心脏T细胞反应的表型研究

心肌梗死引起的持续性心脏T细胞反应与随后的不良心室重塑和心力衰竭进展有关,目前尚无T细胞受体(TCR)剧集的变化与缺血心力衰竭心脏T细胞表型特征结合的数据。通过高通量测序对TCR基因序列的分析发现,与对照心脏的T细胞相比,缺血衰竭心脏的TCR基因序列呈克隆性扩展,但TRBV-J重排和V基因片段的使用模式相似。与外周血T细胞相比,缺血衰竭心脏中的T细胞具有限制性和克隆性扩张的TCR序列,TRBV-J